HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Mark G. Hazekamp Nanning Anes Paul H. Schoof Robert A.E. Dion Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Draaisma, A. M. Articles by Dion, R. A.E. Search for Related Content PubMed PubMed Citation Articles by Draaisma, A. M. Articles by Dion, R. A.E. Related Collections Extracorporeal circulation

Ann Thorac Surg 2006;81:1455-1459
© 2006 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Phosphorylcholine Coating of Bypass Systems Used for Young Infants Does Not Attenuate the Inflammatory Response

^a Department of Extra Corporeal Circulation, Leiden University Medical Center, Leiden
^b Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden
^c Department of Immunopathology, Sanquin Research at CLB, Amsterdam, the Netherlands
^d Internal Medicine, Academic Medical Center, Amsterdam, the Netherlands

Accepted for publication November 28, 2005.

^_* Address correspondence to Dr Draaisma, Department of ECC, J4-Q-85, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands (Email: a.m.draaisma{at}lumc.nl).

BACKGROUND: Contact of blood with the artificial surfaces of the cardiopulmonary bypass (CPB) system is considered to be a main cause of complement activation. Improving the biocompatibility of the system by reduction of contact activation of blood elements and thereby producing less inflammatory response is evidently desired, especially for neonates and infants who are more susceptible to the deleterious effects of CPB. A phosphorylcholine coating, Phisio, is designed to mimic the natural interfaces of blood. The aim of this study is to compare the influence of a phosphorylcholine-coated CPB system versus an uncoated CPB system on complement activation and clinical outcomes.

METHODS: In this prospective, randomized, blind, one-center study, 28 neonates and infants with a bodyweight between 3 and 6 kg who were undergoing cardiopulmonary bypass were divided in two groups, the phosphorylcholine group and the control group. Thirteen patients were assigned to the phosphorylcholine group and 15 patients to the control group. Patients with Down syndrome, prematurity, cyanosis, or reoperation were excluded. Complement factor C3b/c, human neutrophil elastase (HNE), interleukin-6, and C-reactive protein were measured before, during, and after CPB. Duration of intensive care stay, ventilation time, highest body temperature, and inotropic medication were the clinical variables.

RESULTS: No significant differences were found between the groups for complement factor C3b/c, HNE, interleukin-6, or C-reactive protein during and after CPB. No clinical differences were observed between the groups.

CONCLUSIONS: Phosphorylcholine coating does not attenuate the complement activation during CPB in neonates and infants.

This article has been cited by other articles:

				R. Eggum, T. Ueland, T. E. Mollnes, V. Videm, P. Aukrust, A. E. Fiane, and H. L. Lindberg Effect of Perfusion Temperature on the Inflammatory Response During Pediatric Cardiac Surgery Ann. Thorac. Surg., February 1, 2008; 85(2): 611 - 617. [Abstract] [Full Text] [PDF]

				K. Miyaji, T. Miyamoto, S. Kohira, K. Nakashima, N. Inoue, H. Sato, and K. Ohara Miniaturized cardiopulmonary bypass system in neonates and small infants Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 75 - 79. [Abstract] [Full Text] [PDF]